Novel antibody-drug conjugate eliminates residual cancer cells in majority of patients with B-cell ALL
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Novel antibody-drug conjugate eliminates residual cancer cells in majority of patients with B-cell ALL
Study paves the way for a new drug against metastatic prostate cancer
Study shows that obesity promotes lung cancer by suppressing immune response
Common thyroid hormone may help prevent brain tumour relapse in children, says study
Two in five women with ovarian cancer diagnosed only after emergency admission
New brush test detects oral cancer in one hour
Rare benign kidney tumour case highlights value of biopsy and minimally invasive treatment
Novel biomarker research offers new hope in the fight against colorectal cancer
ESMO GI 2026: Blood test may help identify which colorectal cancer patients with liver metastases are most likely to benefit from chemotherapy after surgery
Study identifies a natural mechanism that limits tumour progression
Researchers develop AI test to predict recurrence of breast cancer
Radioligand therapy significantly prolongs progression-free survival in patients with the most common type of neuroendocrine tumours compared to standard of care